Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | THRB | P10828 | 1/20 | 0.77 |
| ▸ | HTT | P42858 | 1/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.51 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.51 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1627567 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL6554473 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL11594173 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL11593906 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL965023 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL2123908 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL15972698 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL965021 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL1627566 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL30104751 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117500747-A | System and method for color forming solutions for aqueous structures | 塞浦里斯材料股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| EP-4291524-A1 | SYSTEM AND METHOD FOR AN AQUEOUS STRUCTURAL COLOR FORMING SOLUTION | Cypris Materials Inc. (US) | 2023-12-20 | — | — | EP | claimed |
| WO-2022198056-A1 | SYSTEM AND METHOD FOR AN AQUEOUS STRUCTURAL COLOR FORMING SOLUTION | Cypris Materials Inc. (US) | 2022-09-22 | — | — | WO | claimed |
| US-20220298368-A1 | SYSTEM AND METHOD FOR AN AQUEOUS STRUCTURAL COLOR FORMING SOLUTION | Cypris Materials Inc. | 2022-09-22 | — | — | US | claimed |
| US-4986851-A | MIXTURE OF ORGANIC SULFATE AND PHOSPHATE DISPERSANTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-01-22 | — | — | US | claimed |
| US-12331265-B2 | Hard surface disinfecting composition comprising a C2-C4 alcohol and peroxymonosulfate anion | Next Science IP Holdings Pty Ltd (AU) | 2025-06-17 | — | — | US | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| CN-118724721-A | Fuel lubricity improver and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118076767-A | Method and formulation for producing an optical metal oxide layer | 默克专利有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20230380420-A1 | HARD SURFACE DISINFECTING COMPOSITION | Next Science IP Holdings Pty Ltd (AU) | 2023-11-30 | — | — | US | disclosed |
| CN-111918634-B | Non-aluminum antiperspirant compositions | 联合利华知识产权控股有限公司 | 2023-11-03 | — | — | CN | disclosed |
| US-11723361-B2 | Antimicrobial composition having efficacy against endospores | Next Science IP Holdings Pty Ltd (AU) | 2023-08-15 | — | — | US | disclosed |
| US-20030235603-A1 | Multiphase polymeric drug release region | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-25 | — | — | US | disclosed |
| US-20030236514-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-25 | — | — | US | disclosed |
| US-20030236513-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | SCIMED LIFE SYSTEMS, INC. | 2003-12-25 | — | — | US | disclosed |
| US-20030203000-A1 | Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques | BOSTON SCIENTIFIC SCIMED, INC. | 2003-10-30 | — | — | US | disclosed |
| US-6558432-B2 | After an organic solvent cleaning cycle, the solvent is extracted from the textiles at high speed in a rotating drum; extracted textiles are then immersed in pressurized fluid solvent to extract the residual organic solvent | R. R. STREET & CO., INC. | 2003-05-06 | — | — | US | disclosed |
| WO-2002086222-A1 | CLEANING SYSTEM UTILIZING AN ORGANIC CLEANING SOLVENT AND A PRESSURIZED FLUID SOLVENT | SCHULTE JAMES E (US) | 2002-10-31 | — | — | WO | disclosed |
| US-20020010965-A1 | Cleaning system utilizing an organic cleaning solvent and a pressurized fluid solvent | CONVERGENT CAPITAL PARTNERS III, L.P. | 2002-01-31 | — | — | US | disclosed |
| US-4986851-A | MIXTURE OF ORGANIC SULFATE AND PHOSPHATE DISPERSANTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11723361-B2 | Antimicrobial composition having efficacy against endospores | OAT, CTSA, HAO2 | MEN1 1498/4885THRB 4699/4885HTT 2549/4885 |
| US-20030203000-A1 | Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques | ABCB11, LPXN, LIPA | MEN1 2979/4885THRB 2666/4885HTT 579/4885 |
| US-20230380420-A1 | HARD SURFACE DISINFECTING COMPOSITION | CD44, LPO, ODC1 | MEN1 3959/4885THRB 3194/4885HTT 3762/4885 |
| US-20030235603-A1 | Multiphase polymeric drug release region | ABCB11, ABCB1, PIK3R1 | MEN1 1862/4885THRB 1845/4885HTT 1354/4885 |
| US-12331265-B2 | Hard surface disinfecting composition comprising a C2-C4 alcohol and peroxymonosulfate anion | ADH1C, AOC3, ADH5 | MEN1 3402/4885THRB 3255/4885HTT 4220/4885 |
| US-20030236514-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | MLEC, CA6, MIF | MEN1 180/4885THRB 4069/4885HTT 4558/4885 |
| US-20030236513-A1 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | PAICS, MIF, PGF | MEN1 1792/4885THRB 2579/4885HTT 3549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.